Kátia Roque Perez (Katia Roque)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Patient Satisfaction

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy 16 (4) (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy 16 (4) (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy 16 (4) (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Puteri Abdul Haris
What is the future of immune checkpoints inhibitors for metastatic triple negative breast cancers? Immunotherapy (2024)
Ramon Andrade Bezerra De Mello, Kátia Roque Perez, Thais Pérez Vazquez
Current and future trends in neoadjuvant immunotherapy for the treatment of triple-negative breast cancer. Immunotherapy (2024)
Kátia Roque Perez, Rossana Ruiz, Luis Mas, Daniel Humberto Pozza, Marina Vancini, José Antônio Silva Júnior, Ramon Andrade Bezerra De Mello
Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices. Cancers 15 (18) (2023)
Kátia Roque Perez, Rossana Ruiz, Iris Otoya-Fernandez, José Galarreta, Tatiana Vidaurre, Ramon Andrade Bezerra De Mello, Silvia P Neciosup, Luis Mas, Henry L Gómez
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic. Future oncology (London, England) (2022)
Marco Gálvez-Nino, Rossana Ruiz, Kátia Roque Perez, Ofelia Coanqui, Natalia Valdivieso, Mivael Olivera, Apar Kishor Ganti, Luis Mas
Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru. Thoracic cancer (2022)
Marco Gálvez-Nino, Rossana Ruiz, Joseph A Pinto, Kátia Roque Perez, Raul Mantilla, Luis E Raez, Luis Mas
Lung Cancer in the Young. Lung 198 (1) (2019)